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Neisseria meningitidis Serogroup
W135 Isolates Associated with
the ET-37 Complex
To the Editor: As of April 20, 2000, >300 labora-
tory-confirmed cases of meningococcal disease
caused by N. meningitidis serogroup W135
(NMW135) have been reported in Saudi Arabia
and nine other countries among Hajj pilgrims
or their close contacts (1). This is the first
reported multinational outbreak of W135
meningococcal disease. NMW135 accounts for
<5% of meningococcal disease in the United
States and worldwide. The main cause of
meningococcal disease outbreaks, especially in
the African “meningitis belt,” which extends
from Ethiopia in the east to Senegal in the
west, has long been N. meningitidis serogroup
A. An epidemic, caused by a particular clonal
group of serogroup A, identified by multilocus
enzyme electrophoresis (MEE) as subgroup
III-1, occurred in Nepal (1983 and 1984),
Pakistan, and India (1985) (2) and may have
caused earlier epidemics in China. In 1987, an
outbreak of group A meningococcal disease
caused by the same clonal group occurred in
association with the annual Moslem pilgrimage
to Mecca (Hajj) (3). At that time, Saudi Arabia
implemented vaccination requirements for all
entering pilgrims. The vaccine formulations
vary; bivalent A/C vaccine or quadrivalent A/C/
Y/W135 vaccine (as licensed in the United
States) is used.
We present molecular characterization
results of NMW135 isolates from four U.S.
patients with meningococcal disease. These
cases were epidemiologically linked to this
year’s Hajj in Saudi Arabia, which concluded
on March 17, 2000 (4). We examine the origin
and potential relatedness of the NMW135
isolates to some of the major N. meningitidis
virulent clones. Two patients (both vaccinated
with quadrivalent A/C/Y/W135 vaccine) were
returning pilgrims; one was a close household
contact of another pilgrim, the other had other
possible contacts with the U.S. pilgrims. Three
isolates were identified as NMW135 at the New
York City Health Department and the fourth at
the California Department of Health. Serogroup
identification was confirmed at the Centers for
Disease Control and Prevention (CDC) by
standard microbiologic methods (5).
MEE has long been the standard method for
molecular subtyping of N. meningitidis and has
allowed identification of several major epi-
demic-prone clones. When the MEE system
established by Caugant et al. (6) and that used
at CDC were recently compared, they demon-
strated excellent correlation segregating indi-
vidual electrophoretic types (ETs) into similar
clusters. A virulent clone, designated ET-37
complex, which contains >50 different ETs, is
mainly composed of N. meningitidis serogroup
C. In the United States, strains of ET-24
(within the ET-37 complex) are the main cause
of meningococcal disease outbreaks and among
the most frequent causes of sporadic meningo-
coccal disease (7). The four Hajj-associated
NMW135 isolates were of ET-927, which is
located in a small cluster more closely related to
the ET-37 complex (at a genetic distance <0.20)
than to any other NMW135 isolate or any other
major virulent clonal group among >2,000
N. meningitidis isolates in our collection (8).
This cluster contains two other NMW135
isolates: one from Indonesia from a pilgrim
returning from the 1996 Hajj and another from
Canada (1997) for which additional epidemio-
logic information is not available.
Serotyping and serosubtyping showed that
all four W135 isolates were 2a:P1.5,2, most
frequently seen in N. meningitidis serogroup B
and C isolates (9). Sequencing of the variable
regions (VR) of the porA gene showed that
these four isolates had VR1 and VR2 sequences
identical to those of the prototype P1.5,2 strain.
Strains of the same serogroup/serosubtype have
been already identified in France and the
Netherlands isolated from four patients with
Hajj 2000 association (1), and earlier in Gambia
(1990-1995) and Mali (1995) (10). A single
NMW135 isolate from Gambia and one from
Mali are listed in the multilocus sequence
typing (MLST) database (Oxford database) as
being of sequence type 11, typically seen in
isolates of the ET-37 complex (11). MLST
provides results comparable to those of MEE for
classification and taxonomic purposes. We are
evaluating the usefulness of MLST for outbreak
studies. The DNA sequences of the 16S rRNA
gene of the four Hajj-associated NMW135
isolates were identical to each other and to
those of the California (1995) outbreak-related
serogroup C ET-24 strains and an Ohio (1997)
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sporadic serogroup C ET-24 strain. The 16S
rRNA gene sequences of 66 N. meningitidis
isolates representing serogroups A, B, C, W135,
Z, and Y were diverse, with nine different
sequences among the NMW135 isolates. Fi-
nally, all four recent NMW135 isolates had
identical NheI pulsed-field gel electrophoresis
(PFGE) patterns distinct from patterns seen in
other NMW135 isolates. All these molecular
markers were clearly unique in NMW135
isolates previously identified in the United
States or isolated at the same time as the Hajj-
associated isolates but with no epidemiologic
link to the current outbreak. These unique
markers allowed easy differentiation of the
imported, Hajj-associated isolates from other
sporadic NMW135 isolates circulating in the
United States.
It has been shown previously that NMW135
strains can exist in widely divergent clonal
groups. Our data suggest that strains like those
associated with this year’s Hajj have been in
circulation in human populations for at least
several years in different parts of the world.
Given that the Hajj is a large, yearly event,
high-level exposure of pilgrims to respiratory
secretions and subsequent spread of infection to
many countries by returning pilgrims may turn
W135 meningococcal disease into a global
health threat. Continued surveillance, as well as
increased awareness of meningococcal disease
caused by N. meningitidis of this serogroup by
physicians and the public, is needed. Efforts to
measure the efficacy of the quadrivalent menin-
gococcal vaccine for prevention of W135 menin-
gococcal disease should be considered. To get a
better global understanding of W135 meningo-
coccal disease, we are conducting a large
multicenter study on molecular characteriza-
tion of >50 Hajj-associated NMW135 isolates
from Saudi Arabia, France, Singapore, and
Finland, and 50 other W135 isolates from
throughout the world.
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Gnathostomosis in Fish from Tres
Palos Lagoon, Guerrero, Mexico
To the Editor: Since the first two cases of
human gnathostomosis in Mexico were re-
ported in 1970 (1), >1,500 cases have been
reported in Nayarit, Sinaloa, Oaxaca, Guerrero,
Veracruz, and Tamaulipas states (2). In
Acapulco, Guerrero, 98 cases have been de-
scribed; the intermediate or definitive hosts in
this region are unknown (3,4).
